SEC Form 4/A · accession 0001209191-16-140610
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
James T Lafrance
Director
Period of report
Aug 26, 2016
Accepted (ET)
Sep 8, 2016 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.46 | Aug 26, 2016 | A | 5,000 | A | — | Aug 25, 2026 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1This Form 4 is being amended to correct the vesting schedule of the stock option as follows: One third of the shares vest on December 1, 2016 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on December 1, 2018.